Physician profile
Cheryl A Stallo
NPI 1881322600
$2,191.84
in general payments reported to CMS, 2019-2025
10 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $98.94 · 2023: $300 · 2024: $98.06 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.75 |
| Travel and Lodging | $723.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,406.08 | 2024-2025 | Activ.A.C., Bair Hugger, 3m Cavilon |
| Organogenesis INC. | $532.68 | 2022-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Urgo Medical North America, LLC | $68.63 | 2025 | Urgok2 |
| Boston Scientific Corporation | $48.63 | 2025 | Angiojet Ultra 5000a |
| Kci USA, INC. | $35.83 | 2023 | Activ.A.C., Promogran Prisma |
| Hydrofera LLC | $25.68 | 2024 | Hydrofera Blue |
| Kerecis Limited | $25.40 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $21.25 | 2025 | Tcc-Ez |
| Smith+Nephew, INC. | $18.82 | 2025 | Pico |
| Cashflow Solutions, LLC | $8.84 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Stallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.